These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 13451191)

  • 1. [Data on biology of Shigella sonnei. I. Biological effect of total Shigella sonnei antigen].
    DIACHENKO SS; BERNASOVS'KA EP; ANCHEVS'KA MS
    Mikrobiol Zh; 1957; 19(1):44-8. PubMed ID: 13451191
    [No Abstract]   [Full Text] [Related]  

  • 2. [Data on biology of Shigella sonnei. II. Antigenic properties of total antigen of Shigella sonnei].
    DIACHENKO SS; BERNASOVS'KA EP; ANCHEVS'KA MS; IAKUBOS'KA LI
    Mikrobiol Zh; 1957; 19(1):49-53. PubMed ID: 13451192
    [No Abstract]   [Full Text] [Related]  

  • 3. Acanthamoeba castellanii an environmental host for Shigella dysenteriae and Shigella sonnei.
    Saeed A; Abd H; Edvinsson B; Sandström G
    Arch Microbiol; 2009 Jan; 191(1):83-8. PubMed ID: 18712360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detecting low concentrations of Shigella sonnei in environmental water samples by PCR.
    Hsu WB; Wang JH; Chen PC; Lu YS; Chen JH
    FEMS Microbiol Lett; 2007 May; 270(2):291-8. PubMed ID: 17391373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Precise identification of strain called "paradysenteriae Y6R" or "Flexner Y6R" (Burnet)].
    Szturm-Rubinsten ; Piéchaud M
    Ann Inst Pasteur (Paris); 1968 Sep; 115(3):386-90. PubMed ID: 4886012
    [No Abstract]   [Full Text] [Related]  

  • 6. Isolation of a rough somatic antigen from Shigella dysenteriae.
    DAVIES DA
    Biochim Biophys Acta; 1957 Oct; 26(1):151-8. PubMed ID: 13479473
    [No Abstract]   [Full Text] [Related]  

  • 7. Vaccine potential for inactivated shigellae.
    Osorio M; Bray MD; Walker RI
    Vaccine; 2007 Feb; 25(9):1581-92. PubMed ID: 17178431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro adhesion and invasion inhibition of Shigella dysenteriae, Shigella flexneri and Shigella sonnei clinical strains by human milk proteins.
    Willer Eda M; Lima Rde L; Giugliano LG
    BMC Microbiol; 2004 Apr; 4():18. PubMed ID: 15115555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Phage control of the synthesis of group-specific antigen 7,8 in Shigella flexneri].
    Petrovskaia VG; Bondarenko VM
    Vestn Akad Med Nauk SSSR; 1969; 24(12):52-6. PubMed ID: 4918177
    [No Abstract]   [Full Text] [Related]  

  • 10. [Significance of quantitative content of complete antigen in Shigella dysenteriae cultures in lytic activity of bacteriophage].
    PEREMITINA LD
    Zh Mikrobiol Epidemiol Immunobiol; 1957 Jul; 28(7):56-61. PubMed ID: 13497215
    [No Abstract]   [Full Text] [Related]  

  • 11. Shigellosis: the current status of vaccine development.
    Kweon MN
    Curr Opin Infect Dis; 2008 Jun; 21(3):313-8. PubMed ID: 18448978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An immunologic comparison of cell components of Shigella dysenteriae type 2.
    COOPER GN; PILLOW JA
    J Immunol; 1960 Feb; 84():135-42. PubMed ID: 13811788
    [No Abstract]   [Full Text] [Related]  

  • 13. [Immunological characteristics of Shigella dysenteriae strains isolated in the onset and in the terminal stages of disease].
    GROMOV AS; SIL'CHENKO Ts; PAFNUT'EVA GV
    Zh Mikrobiol Epidemiol Immunobiol; 1958 Apr; 29(4):93-4. PubMed ID: 13570486
    [No Abstract]   [Full Text] [Related]  

  • 14. [Fluorescein-labeled antibodies for the detection of Shigella dysenteriae. I].
    KABANOVA EA; GLUBOKINA AI
    Zh Mikrobiol Epidemiol Immunobiol; 1958 Jan; 29(1):5-8. PubMed ID: 13570351
    [No Abstract]   [Full Text] [Related]  

  • 15. Antimicrobial resistance in Shigella species isolated in Dakar, Senegal (2004-2006).
    Sire JM; Macondo EA; Perrier-Gros-Claude JD; Siby T; Bahsoun I; Seck A; Garin B
    Jpn J Infect Dis; 2008 Jul; 61(4):307-9. PubMed ID: 18653976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and immunogenicity of WRSd1, a live attenuated Shigella dysenteriae type 1 vaccine candidate.
    McKenzie R; Venkatesan MM; Wolf MK; Islam D; Grahek S; Jones AM; Bloom A; Taylor DN; Hale TL; Bourgeois AL
    Vaccine; 2008 Jun; 26(26):3291-6. PubMed ID: 18468742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of Shigella enterotoxin genes and secreted autotransporter toxin gene among diverse species and serotypes of shigella isolated from Andaman Islands, India.
    Roy S; Thanasekaran K; Dutta Roy AR; Sehgal SC
    Trop Med Int Health; 2006 Nov; 11(11):1694-8. PubMed ID: 17054749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative microassay in cell culture for enterotoxin of Shigella dysenteriae.
    Keusch GT; Jacewicz M; Hirschman SZ
    J Infect Dis; 1972 May; 125(5):539-41. PubMed ID: 4554110
    [No Abstract]   [Full Text] [Related]  

  • 19. Laboratory-confirmed shigellosis in the United States, 1989-2002: epidemiologic trends and patterns.
    Gupta A; Polyak CS; Bishop RD; Sobel J; Mintz ED
    Clin Infect Dis; 2004 May; 38(10):1372-7. PubMed ID: 15156473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shigella isolates of Nepal: changes in the incidence of shigella subgroups and trends of antimicrobial susceptibility pattern.
    Kansakar P; Malla S; Ghimire GR
    Kathmandu Univ Med J (KUMJ); 2007; 5(1):32-7. PubMed ID: 18603983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.